Indian Drug Manufacturers’ Association (Indian Drug Manufacturers’ Association) warned that the suspension of some Chinese cargo flights could disrupt the global drug supply chain.
Foreign wire reports, the United States relies heavily on India’s drug supply, any slowdown in production may lead to a shortage of commonly used drugs in pharmacies. China’s Sichuan Airlines suspended cargo flights to India for the next 15 days on April 26, and Mahesh Doshi, head of the Indian Pharmaceutical Manufacturers Association, noted that China supplies 60 to 70 percent of Indian drugmakers’ raw materials, as well as finished drug ingredients destined for the global market. If the flights continue to be suspended, the pharmaceutical industry fears that it will cause a knock-on effect on the entire supply chain, which could lead to a shortage of essential drugs within India and seriously affect exports.
Reports indicate that the United States Pharmacopeia (USP), which assists the pharmaceutical industry in quality control, has launched a project to identify the place of production as far as possible, and its spokesman Anne Bell said that the “Drug Supply Map” has identified the place of production of 77% of the scientific name drugs, 62 scientific name drugs are produced only in India, including several antibacterial drugs, antiviral drugs. Antiviral drugs. According to the U.S. Food and Drug Administration (FDA) data, in the United States approved applications, 31% of the production of APIs from India.
Recent Comments